Humacyte (HUMA) Inventory (2025 - 2026)

Humacyte (HUMA) reported Inventory of $20.4 million for Q1 2026, up 155.0% year-over-year from $8.0 million in Q1 2025, and down 9.33% quarter-over-quarter from $22.5 million in Q4 2025.

Humacyte (HUMA) Inventory (2025 - 2026) Analysis & Trends

Humacyte (HUMA) has 2 years of Inventory data on file, last reported at $20.4 million in Q1 2026.

  • Inventory for Q1 2026 came in at $20.4 million, up 155.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $20.4 million (up 155.0% YoY), and the FY2025 annual result was $22.5 million, changed N/A from the prior year.
  • Inventory declined to $20.4 million in Q1 2026 per HUMA's latest filing, from $22.5 million in the prior quarter.
  • Over five years, Inventory peaked at $22.5 million in Q4 2025 and troughed at $8.0 million in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inventory (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 32.00 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 1.77 Bn
9 Abivax 91.96 Bn 91.96 Bn - -
10 Humacyte 183.21 Mn 134.67 Mn -1.54 Mn 20.40 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 20.40 Mn
Dec 31, 2025 22.50 Mn
Sep 30, 2025 18.40 Mn
Jun 30, 2025 11.10 Mn
Mar 31, 2025 8.00 Mn